Cargando…
P1198: ASSOCIATION OF PRETREATMENT TUMOR CHARACTERISTICS AND CLINICAL OUTCOMES FOLLOWING SECOND-LINE AXICABTAGENE CILOLEUCEL VS STANDARD OF CARE IN PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA
| Autores principales: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431362/ http://dx.doi.org/10.1097/01.HS9.0000847656.43400.7a |
| _version_ | 1784780034177761280 |
|---|---|
| author | Locke, F. L. Chou, J. Vardhanabhuti, S. Perbost, R. Dreger, P. Hill, B. T. Lee, C. Zinzani, P. L. Kröger, N. López-Guillermo, A. Greinix, H. Zhang, W. Tiwari, G. To, C. Cheng, P. Bot, A. Shen, R. Filosto, S. Galon, J. |
| author_facet | Locke, F. L. Chou, J. Vardhanabhuti, S. Perbost, R. Dreger, P. Hill, B. T. Lee, C. Zinzani, P. L. Kröger, N. López-Guillermo, A. Greinix, H. Zhang, W. Tiwari, G. To, C. Cheng, P. Bot, A. Shen, R. Filosto, S. Galon, J. |
| author_sort | Locke, F. L. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9431362 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94313622022-08-31 P1198: ASSOCIATION OF PRETREATMENT TUMOR CHARACTERISTICS AND CLINICAL OUTCOMES FOLLOWING SECOND-LINE AXICABTAGENE CILOLEUCEL VS STANDARD OF CARE IN PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA Locke, F. L. Chou, J. Vardhanabhuti, S. Perbost, R. Dreger, P. Hill, B. T. Lee, C. Zinzani, P. L. Kröger, N. López-Guillermo, A. Greinix, H. Zhang, W. Tiwari, G. To, C. Cheng, P. Bot, A. Shen, R. Filosto, S. Galon, J. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9431362/ http://dx.doi.org/10.1097/01.HS9.0000847656.43400.7a Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Locke, F. L. Chou, J. Vardhanabhuti, S. Perbost, R. Dreger, P. Hill, B. T. Lee, C. Zinzani, P. L. Kröger, N. López-Guillermo, A. Greinix, H. Zhang, W. Tiwari, G. To, C. Cheng, P. Bot, A. Shen, R. Filosto, S. Galon, J. P1198: ASSOCIATION OF PRETREATMENT TUMOR CHARACTERISTICS AND CLINICAL OUTCOMES FOLLOWING SECOND-LINE AXICABTAGENE CILOLEUCEL VS STANDARD OF CARE IN PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA |
| title | P1198: ASSOCIATION OF PRETREATMENT TUMOR CHARACTERISTICS AND CLINICAL OUTCOMES FOLLOWING SECOND-LINE AXICABTAGENE CILOLEUCEL VS STANDARD OF CARE IN PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA |
| title_full | P1198: ASSOCIATION OF PRETREATMENT TUMOR CHARACTERISTICS AND CLINICAL OUTCOMES FOLLOWING SECOND-LINE AXICABTAGENE CILOLEUCEL VS STANDARD OF CARE IN PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA |
| title_fullStr | P1198: ASSOCIATION OF PRETREATMENT TUMOR CHARACTERISTICS AND CLINICAL OUTCOMES FOLLOWING SECOND-LINE AXICABTAGENE CILOLEUCEL VS STANDARD OF CARE IN PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA |
| title_full_unstemmed | P1198: ASSOCIATION OF PRETREATMENT TUMOR CHARACTERISTICS AND CLINICAL OUTCOMES FOLLOWING SECOND-LINE AXICABTAGENE CILOLEUCEL VS STANDARD OF CARE IN PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA |
| title_short | P1198: ASSOCIATION OF PRETREATMENT TUMOR CHARACTERISTICS AND CLINICAL OUTCOMES FOLLOWING SECOND-LINE AXICABTAGENE CILOLEUCEL VS STANDARD OF CARE IN PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA |
| title_sort | p1198: association of pretreatment tumor characteristics and clinical outcomes following second-line axicabtagene ciloleucel vs standard of care in patients with relapsed/refractory large b-cell lymphoma |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431362/ http://dx.doi.org/10.1097/01.HS9.0000847656.43400.7a |
| work_keys_str_mv | AT lockefl p1198associationofpretreatmenttumorcharacteristicsandclinicaloutcomesfollowingsecondlineaxicabtageneciloleucelvsstandardofcareinpatientswithrelapsedrefractorylargebcelllymphoma AT chouj p1198associationofpretreatmenttumorcharacteristicsandclinicaloutcomesfollowingsecondlineaxicabtageneciloleucelvsstandardofcareinpatientswithrelapsedrefractorylargebcelllymphoma AT vardhanabhutis p1198associationofpretreatmenttumorcharacteristicsandclinicaloutcomesfollowingsecondlineaxicabtageneciloleucelvsstandardofcareinpatientswithrelapsedrefractorylargebcelllymphoma AT perbostr p1198associationofpretreatmenttumorcharacteristicsandclinicaloutcomesfollowingsecondlineaxicabtageneciloleucelvsstandardofcareinpatientswithrelapsedrefractorylargebcelllymphoma AT dregerp p1198associationofpretreatmenttumorcharacteristicsandclinicaloutcomesfollowingsecondlineaxicabtageneciloleucelvsstandardofcareinpatientswithrelapsedrefractorylargebcelllymphoma AT hillbt p1198associationofpretreatmenttumorcharacteristicsandclinicaloutcomesfollowingsecondlineaxicabtageneciloleucelvsstandardofcareinpatientswithrelapsedrefractorylargebcelllymphoma AT leec p1198associationofpretreatmenttumorcharacteristicsandclinicaloutcomesfollowingsecondlineaxicabtageneciloleucelvsstandardofcareinpatientswithrelapsedrefractorylargebcelllymphoma AT zinzanipl p1198associationofpretreatmenttumorcharacteristicsandclinicaloutcomesfollowingsecondlineaxicabtageneciloleucelvsstandardofcareinpatientswithrelapsedrefractorylargebcelllymphoma AT krogern p1198associationofpretreatmenttumorcharacteristicsandclinicaloutcomesfollowingsecondlineaxicabtageneciloleucelvsstandardofcareinpatientswithrelapsedrefractorylargebcelllymphoma AT lopezguillermoa p1198associationofpretreatmenttumorcharacteristicsandclinicaloutcomesfollowingsecondlineaxicabtageneciloleucelvsstandardofcareinpatientswithrelapsedrefractorylargebcelllymphoma AT greinixh p1198associationofpretreatmenttumorcharacteristicsandclinicaloutcomesfollowingsecondlineaxicabtageneciloleucelvsstandardofcareinpatientswithrelapsedrefractorylargebcelllymphoma AT zhangw p1198associationofpretreatmenttumorcharacteristicsandclinicaloutcomesfollowingsecondlineaxicabtageneciloleucelvsstandardofcareinpatientswithrelapsedrefractorylargebcelllymphoma AT tiwarig p1198associationofpretreatmenttumorcharacteristicsandclinicaloutcomesfollowingsecondlineaxicabtageneciloleucelvsstandardofcareinpatientswithrelapsedrefractorylargebcelllymphoma AT toc p1198associationofpretreatmenttumorcharacteristicsandclinicaloutcomesfollowingsecondlineaxicabtageneciloleucelvsstandardofcareinpatientswithrelapsedrefractorylargebcelllymphoma AT chengp p1198associationofpretreatmenttumorcharacteristicsandclinicaloutcomesfollowingsecondlineaxicabtageneciloleucelvsstandardofcareinpatientswithrelapsedrefractorylargebcelllymphoma AT bota p1198associationofpretreatmenttumorcharacteristicsandclinicaloutcomesfollowingsecondlineaxicabtageneciloleucelvsstandardofcareinpatientswithrelapsedrefractorylargebcelllymphoma AT shenr p1198associationofpretreatmenttumorcharacteristicsandclinicaloutcomesfollowingsecondlineaxicabtageneciloleucelvsstandardofcareinpatientswithrelapsedrefractorylargebcelllymphoma AT filostos p1198associationofpretreatmenttumorcharacteristicsandclinicaloutcomesfollowingsecondlineaxicabtageneciloleucelvsstandardofcareinpatientswithrelapsedrefractorylargebcelllymphoma AT galonj p1198associationofpretreatmenttumorcharacteristicsandclinicaloutcomesfollowingsecondlineaxicabtageneciloleucelvsstandardofcareinpatientswithrelapsedrefractorylargebcelllymphoma |